Outer Bio Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$23.3M
- Investors
-
11
Outer Bio General Information
Description
Developer of a dermatology technology designed to improve human skin health by discovering and developing novel bioactive compounds that are effective and safe. The company's technology utilizes an integrated discovery engine combining long-lasting ex vivo skin models, multimodal data analysis, and predictive machine learning, enabling the biotechnology and pharmaceutical industries to identify and prioritize effective compounds for skincare and dermatological applications.
Contact Information
Website
www.outerbio.comCorporate Office
- 200 Exchange Street
- Suite 301
- Malden, MA 02148
- United States
Corporate Office
- 200 Exchange Street
- Suite 301
- Malden, MA 02148
- United States
Outer Bio Timeline
Outer Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 21-Aug-2026 | $23.3M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 28-Jun-2024 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Outer Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Outer Bio Patents
Outer Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4677065-A1 | Systems and processes for skin tissue growth and analysis | Pending | 06-Mar-2023 | ||
| US-20260002109-A1 | Systems and processes for skin tissue growth and analysis | Pending | 06-Mar-2023 | ||
| WO-2024186903-A1 | Systems and processes for skin tissue growth and analysis | Inactive | 06-Mar-2023 | C12M21/08 |
Outer Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Outer Bio Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Initialized Capital | Venture Capital | Minority | ||
| Lightspeed Venture Partners | Venture Capital | Minority | ||
| SV Angel | Venture Capital | Minority | ||
| Third Kind Venture Capital | Venture Capital | Minority | ||
| Wing Venture Capital | Venture Capital | Minority |
Outer Bio FAQs
-
When was Outer Bio founded?
Outer Bio was founded in 2020.
-
Where is Outer Bio headquartered?
Outer Bio is headquartered in Malden, MA.
-
What is the size of Outer Bio?
Outer Bio has 19 total employees.
-
What industry is Outer Bio in?
Outer Bio’s primary industry is Discovery Tools (Healthcare).
-
Is Outer Bio a private or public company?
Outer Bio is a Private company.
-
What is Outer Bio’s current revenue?
The current revenue for Outer Bio is .
-
How much funding has Outer Bio raised over time?
Outer Bio has raised $27.3M.
-
Who are Outer Bio’s investors?
Initialized Capital, Lightspeed Venture Partners, SV Angel, Third Kind Venture Capital, and Wing Venture Capital are 5 of 11 investors who have invested in Outer Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
